Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jan;81(1):143-145.
doi: 10.1136/annrheumdis-2021-220549. Epub 2021 Sep 23.

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

Renaud Felten  1   2 , Pierre-Marie Duret  3 , Elodie Bauer  4 , Nathanael Sedmak  5 , Julien H Djossou  6 , Massiva Bensalem  1 , Marc Ardizzone  7 , Marion Geoffroy  8 , Angelique Fan  9 , Marion Couderc  9 , Jean Hugues Salmon  8   10 , Laurent Messer  3 , Rose-Marie Javier  1 , Alain Meyer  1 , Emmanuel Chatelus  1 , Christelle Sordet  1 , Luc Pijnenburg  1 , Jérémy Fort  1 , Marina Rinagel  1 , Julia Walther  11 , Cassandre Fabre  11 , Laurent Arnaud  1 , Jean Sibilia  1 , Nicolas Meyer  5 , Francis Berenbaum  6   12 , Isabelle Chary-Valckenaere  4 , Martin Soubrier  9 , Jérémie Sellam  6   12 , Jacques-Eric Gottenberg  13   2
Affiliations
Multicenter Study

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

Renaud Felten et al. Ann Rheum Dis. 2022 Jan.
No abstract available

Keywords: Biological Therapy; Covid-19; Rituximab; Therapeutics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

MeSH terms